620 related articles for article (PubMed ID: 11012914)
1. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
[TBL] [Abstract][Full Text] [Related]
2. [Long-term stability of bone mineral density in patients with renal transplant treated with cyclosporine and low doses of corticoids. Protective role of cyclosporine?].
Ezaitouni F; Westeel PF; Fardellone P; Mazouz H; Brazier M; el Esper I; Sebert JL; Petit J; Westeel A; Pruna A; Fournier A
Presse Med; 1998 Apr; 27(15):705-12. PubMed ID: 9767908
[TBL] [Abstract][Full Text] [Related]
3. Pamidronate therapy as prevention of bone loss following renal transplantation.
Fan SL; Almond MK; Ball E; Evans K; Cunningham J
Kidney Int; 2000 Feb; 57(2):684-90. PubMed ID: 10652047
[TBL] [Abstract][Full Text] [Related]
4. Rapid loss of vertebral mineral density after renal transplantation.
Julian BA; Laskow DA; Dubovsky J; Dubovsky EV; Curtis JJ; Quarles LD
N Engl J Med; 1991 Aug; 325(8):544-50. PubMed ID: 1857390
[TBL] [Abstract][Full Text] [Related]
5. Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone.
Casez JP; Lippuner K; Horber FF; Montandon A; Jaeger P
Nephrol Dial Transplant; 2002 Jul; 17(7):1318-26. PubMed ID: 12105258
[TBL] [Abstract][Full Text] [Related]
6. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
7. Evolution of bone disease at 2 years after transplantation: a single-center study.
Falkiewicz K; Boratyńska M; Zmonarski SC; Milewicz A; Patrzałek D; Biecek P; Klinger M
Transplant Proc; 2009 Oct; 41(8):3063-6. PubMed ID: 19857677
[TBL] [Abstract][Full Text] [Related]
8. Comparison of calcium and alfacalcidol supplement in the prevention of osteopenia after kidney transplantation.
Berczi C; Asztalos L; Kincses Z; Balogh A; Löcsey L; Balázs G; Lukács G
Osteoporos Int; 2003 Jun; 14(5):412-7. PubMed ID: 12730763
[TBL] [Abstract][Full Text] [Related]
9. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study.
Marcén R; Caballero C; Pascual J; Teruel JL; Tenorio M; Ocaña J; Villafruela JJ; Burgos FJ; Fernández AM; Muriel A; Ortuño J
Transplantation; 2006 Mar; 81(6):826-31. PubMed ID: 16570003
[TBL] [Abstract][Full Text] [Related]
10. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C
Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
[TBL] [Abstract][Full Text] [Related]
12. [value of bone densitometry in pediatric renal transplantation].
Melgosa Hijosa M; Romero de Paz MD; García Meseguer MC; Alonso Melgar A; Coya J; Navarro M
An Esp Pediatr; 1997 Oct; 47(4):373-7. PubMed ID: 9499304
[TBL] [Abstract][Full Text] [Related]
13. Loss of bone mineral density in renal transplantation recipients.
Unal A; Kocyigit I; Sipahioglu MH; Tokgoz B; Kavuncuoglu F; Oymak O; Utas C
Transplant Proc; 2010 Nov; 42(9):3550-3. PubMed ID: 21094813
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.
Marcén R; Caballero C; Uriol O; Fernández A; Villafruela JJ; Pascual J; Martins J; Rodriguez N; Burgos FJ; Ortuño J
Transplant Proc; 2007 Sep; 39(7):2256-8. PubMed ID: 17889156
[TBL] [Abstract][Full Text] [Related]
15. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
Lane NE; Sanchez S; Genant HK; Jenkins DK; Arnaud CD
Osteoporos Int; 2000; 11(5):434-42. PubMed ID: 10912846
[TBL] [Abstract][Full Text] [Related]
16. Influence of tacrolimus and short-duration prednisone on bone mineral density following liver transplantation.
Scolapio JS; DeArment J; Hurley DL; Romano M; Harnois D; Weigand SD
JPEN J Parenter Enteral Nutr; 2003; 27(6):427-32. PubMed ID: 14621125
[TBL] [Abstract][Full Text] [Related]
17. Determinants of reduced bone mineral density and increased bone turnover after kidney transplantation: cross-sectional study.
Kusec V; Smalcelj R; Cvijetić S; Rozman B; Skreb F
Croat Med J; 2000 Dec; 41(4):396-400. PubMed ID: 11063762
[TBL] [Abstract][Full Text] [Related]
18. Bone loss in long-term renal transplantation: histopathology and densitometry analysis.
Cueto-Manzano AM; Konel S; Hutchison AJ; Crowley V; France MW; Freemont AJ; Adams JE; Mawer B; Gokal R
Kidney Int; 1999 May; 55(5):2021-9. PubMed ID: 10231467
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone.
Duan Y; De Luca V; Seeman E
J Clin Endocrinol Metab; 1999 Feb; 84(2):718-22. PubMed ID: 10022443
[TBL] [Abstract][Full Text] [Related]
20. Abnormal vitamin D metabolism and loss of bone mass after renal transplantation.
de Sévaux RG; Hoitsma AJ; van Hoof HJ; Corstens FJ; Wetzels JF
Nephron Clin Pract; 2003 Jan; 93(1):C21-8. PubMed ID: 12411755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
